- Home
- DLTH vs ENTX Comparison
DLTH vs ENTX Comparison
Compare DLTH & ENTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DLTH | ENTX |
|---|---|---|
| Founded | 1989 | 2010 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 121.1M | 142.0M |
| IPO Year | 2015 | 2018 |
Fundamental Metrics
Financial Performance| Metric | DLTH | ENTX |
|---|---|---|
| Price | $2.94 | $2.16 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $7.00 | ★ $10.00 |
| AVG Volume (30 Days) | ★ 79.2K | 76.2K |
| Earning Date | 12-16-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $602,746,000.00 | $124,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $0.24 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 25.25 |
| 52 Week Low | $1.58 | $1.50 |
| 52 Week High | $4.66 | $3.22 |
Technical Indicators
Market Signals| Indicator | DLTH | ENTX |
|---|---|---|
| Relative Strength Index (RSI) | 44.54 | 40.14 |
| Support Level | $2.86 | $2.07 |
| Resistance Level | $3.57 | $2.27 |
| Average True Range (ATR) | 0.23 | 0.19 |
| MACD | -0.03 | -0.02 |
| Stochastic Oscillator | 7.04 | 15.44 |
Price Performance
Historical ComparisonAbout DLTH Duluth Holdings Inc. Class B
Duluth Holdings Inc is an apparel brand in the United States. The company offers shirts, pants, and casual wear for men and women under brands like Alaskan Hardgear, Armachillo, Ballroom, Cab Commander, Crouch Gusset, Dry on the Fly, Duluth Trading Co, Duluthflex, Fire Hose, Longtail T, No Polo Shirt, No Yank, Wild Boar, and others. The Company's revenue consists of the sale of apparel, footwear, and hard goods. The company operates in a single operating segment.
About ENTX Entera Bio Ltd.
Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.